Published in Science on July 13, 2012
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography. Nat Commun (2014) 3.26
Molecular control of δ-opioid receptor signalling. Nature (2014) 2.22
Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (2012) 2.08
Structure of the adenosine A(2A) receptor bound to an engineered G protein. Nature (2016) 1.84
Structural insights into µ-opioid receptor activation. Nature (2015) 1.77
Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods (2012) 1.75
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Nature (2013) 1.59
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov (2012) 1.50
The role of ligands on the equilibria between functional states of a G protein-coupled receptor. J Am Chem Soc (2013) 1.48
Allosteric sodium in class A GPCR signaling. Trends Biochem Sci (2014) 1.41
High salt recruits aversive taste pathways. Nature (2013) 1.40
Structural basis for bifunctional peptide recognition at human δ-opioid receptor. Nat Struct Mol Biol (2015) 1.32
50 years of allosteric interactions: the twists and turns of the models. Nat Rev Mol Cell Biol (2013) 1.17
The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor. PLoS One (2014) 1.17
Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor. Proc Natl Acad Sci U S A (2013) 1.06
Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective. J Mol Biol (2013) 1.05
Differences in allosteric communication pipelines in the inactive and active states of a GPCR. Biophys J (2014) 1.02
Opioids and their receptors: Are we there yet? Neuropharmacology (2013) 1.01
Femtosecond crystallography of membrane proteins in the lipidic cubic phase. Philos Trans R Soc Lond B Biol Sci (2014) 1.01
Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci (2012) 1.01
Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev (2013) 0.97
Cholesterol as a co-solvent and a ligand for membrane proteins. Protein Sci (2013) 0.97
Principles of allosteric interactions in cell signaling. J Am Chem Soc (2014) 0.97
Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor. Mol Pharmacol (2015) 0.96
The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor. Structure (2013) 0.95
Constitutive phospholipid scramblase activity of a G protein-coupled receptor. Nat Commun (2014) 0.95
Predictions for cholesterol interaction sites on the A2A adenosine receptor. J Am Chem Soc (2012) 0.95
Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates. J Med Chem (2013) 0.94
Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther (2015) 0.94
Structural basis of Smoothened regulation by its extracellular domains. Nature (2016) 0.94
Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun (2015) 0.92
Predicted optical performance of the GM/CA@APS micro-focus beamline. J Phys Conf Ser (2013) 0.92
Probing Gαi1 protein activation at single-amino acid resolution. Nat Struct Mol Biol (2015) 0.91
Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions. Biochemistry (2014) 0.91
G protein-coupled receptors--recent advances. Acta Biochim Pol (2012) 0.90
From atomic structures to neuronal functions of g protein-coupled receptors. Annu Rev Neurosci (2013) 0.90
Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization. Br J Pharmacol (2014) 0.89
GPCR activation: protonation and membrane potential. Protein Cell (2013) 0.89
Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders. Annu Rev Pharmacol Toxicol (2015) 0.89
Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites. Biophys J (2014) 0.89
Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs. Curr Opin Struct Biol (2013) 0.89
Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs. J Chem Inf Model (2014) 0.88
A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor. PLoS One (2013) 0.88
Age-related differences in bitter taste and efficacy of bitter blockers. PLoS One (2014) 0.87
Compound activity prediction using models of binding pockets or ligand properties in 3D. Curr Top Med Chem (2012) 0.87
Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor. Biophys J (2015) 0.87
Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association. PLoS Comput Biol (2015) 0.86
Do plants contain g protein-coupled receptors? Plant Physiol (2013) 0.86
The spatial structure of cell signaling systems. Phys Biol (2013) 0.86
Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations. PLoS Comput Biol (2013) 0.85
Proton transfer-mediated GPCR activation. Protein Cell (2014) 0.85
Native phasing of x-ray free-electron laser data for a G protein-coupled receptor. Sci Adv (2016) 0.84
Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology (2015) 0.83
Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor. J Chem Inf Model (2015) 0.83
Na+ inhibits the epithelial Na+ channel by binding to a site in an extracellular acidic cleft. J Biol Chem (2014) 0.83
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal (2015) 0.83
Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding. PLoS One (2014) 0.82
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs. BMC Biol (2016) 0.82
Analysis of Human Dopamine D3 Receptor Quaternary Structure. J Biol Chem (2015) 0.82
Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor. J Biol Chem (2015) 0.82
Membrane protein structure determination by SAD, SIR, or SIRAS phasing in serial femtosecond crystallography using an iododetergent. Proc Natl Acad Sci U S A (2016) 0.81
The Molecular Mechanism of P2Y1 Receptor Activation. Angew Chem Int Ed Engl (2016) 0.81
Structural dynamics and thermostabilization of neurotensin receptor 1. J Phys Chem B (2015) 0.81
Protein and lipid interactions driving molecular mechanisms of in meso crystallization. J Am Chem Soc (2014) 0.81
Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations. Biochim Biophys Acta (2016) 0.81
Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism. BMC Bioinformatics (2015) 0.81
Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor? Biophys J (2015) 0.81
The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers. Mol Pharmacol (2013) 0.81
Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis. PLoS One (2015) 0.81
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments. Sci Rep (2015) 0.80
Oligomerization and nanocluster organization render specificity. Biol Rev Camb Philos Soc (2014) 0.80
Modulation of GPCRs by monovalent cations and anions. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.80
Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics. Biotechnol J (2012) 0.80
The role of Cysteine 6.47 in class A GPCRs. BMC Struct Biol (2013) 0.80
Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function. Front Physiol (2016) 0.79
Functional assay for T4 lysozyme-engineered G protein-coupled receptors with an ion channel reporter. Structure (2013) 0.79
Large-scale production and protein engineering of G protein-coupled receptors for structural studies. Front Pharmacol (2015) 0.79
Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains. J Biol Chem (2013) 0.79
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor. In Silico Pharmacol (2013) 0.79
How well does cholesteryl hemisuccinate mimic cholesterol in saturated phospholipid bilayers? J Mol Model (2014) 0.79
Programmable nanoscaffolds that control ligand display to a G-protein-coupled receptor in membranes to allow dissection of multivalent effects. J Am Chem Soc (2014) 0.79
Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors. Chem Commun (Camb) (2015) 0.79
High- and low-affinity sites for sodium in δ-OR-Gi1α (Cys (351)-Ile (351)) fusion protein stably expressed in HEK293 cells; functional significance and correlation with biophysical state of plasma membrane. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.79
Stereospecific requirement of cholesterol in the function of the serotonin1A receptor. Biochim Biophys Acta (2013) 0.79
Membrane Protein Structure, Function, and Dynamics: a Perspective from Experiments and Theory. J Membr Biol (2015) 0.79
Role of extracellular cysteine residues in the adenosine A2A receptor. Purinergic Signal (2016) 0.78
Dodecyl maltopyranoside enabled purification of active human GABA type A receptors for deep and direct proteomic sequencing. Mol Cell Proteomics (2014) 0.78
Ligand-dependent cholesterol interactions with the human A(2A) adenosine receptor. Chem Phys Lipids (2013) 0.78
Structural Mechanisms of Voltage Sensing in G Protein-Coupled Receptors. Structure (2016) 0.78
In vitro expression and analysis of the 826 human G protein-coupled receptors. Protein Cell (2016) 0.78
Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept. Mol Pharmacol (2014) 0.78
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17. ACS Med Chem Lett (2014) 0.78
Implementing the "Best Template Searching" tool into Adenosiland platform. In Silico Pharmacol (2013) 0.78
Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor. Angew Chem Int Ed Engl (2016) 0.77
Conserved disulfide bond is not essential for the adenosine A2A receptor: Extracellular cysteines influence receptor distribution within the cell and ligand-binding recognition. Biochim Biophys Acta (2014) 0.77
Coarse-grained molecular dynamics provides insight into the interactions of lipids and cholesterol with rhodopsin. Adv Exp Med Biol (2014) 0.77
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature (2012) 6.18
Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature (2012) 3.83
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature (2012) 3.83
Crystal structure of a lipid G protein-coupled receptor. Science (2012) 3.78
Structure of the δ-opioid receptor bound to naltrindole. Nature (2012) 3.69
Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium. Acta Crystallogr D Biol Crystallogr (2002) 3.55
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature (2012) 2.96
Microscale fluorescent thermal stability assay for membrane proteins. Structure (2008) 2.95
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure (2011) 2.84
HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures. BMC Struct Biol (2008) 2.78
Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci (2009) 2.33
Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (2012) 2.08
Allostery and the Monod-Wyman-Changeux model after 50 years. Annu Rev Biophys (2012) 2.07
Nuclear hormone receptor targeted virtual screening. J Med Chem (2003) 2.05
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc Natl Acad Sci U S A (2009) 2.01
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor. Proc Natl Acad Sci U S A (2008) 1.89
GPCRDB: information system for G protein-coupled receptors. Nucleic Acids Res (2010) 1.77
Biased signalling and allosteric machines: new vistas and challenges for drug discovery. Br J Pharmacol (2012) 1.73
Allosteric modulation of A(2A) adenosine receptors by amiloride analogues and sodium ions. Biochem Pharmacol (2000) 1.67
Regulation of receptor function by cholesterol. Cell Mol Life Sci (2000) 1.67
Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor. Mol Pharmacol (2003) 1.46
Structure based prediction of subtype-selectivity for adenosine receptor antagonists. Neuropharmacology (2010) 1.31
Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol (2010) 1.25
Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Mol Pharmacol (1996) 1.08
Allostery in GPCRs: 'MWC' revisited. Trends Biochem Sci (2011) 1.05
Allosteric modulation of adenosine receptors. Biochim Biophys Acta (2010) 1.01
Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors. Mol Pharmacol (1987) 0.94
Regulation of porcine brain alpha 2-adrenergic receptors by Na+,H+ and inhibitors of Na+/H+ exchange. J Biol Chem (1987) 0.94
An ion-responsive motif in the second transmembrane segment of rhodopsin-like receptors. Amino Acids (2008) 0.88
Signal transduction within G-protein coupled receptors via an ion tunnel: a hypothesis. J Biomol Struct Dyn (1998) 0.86
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
Retraction. Science (2006) 6.95
Crystallizing membrane proteins using lipidic mesophases. Nat Protoc (2009) 6.36
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure (2008) 6.01
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science (2010) 5.86
The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30
Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18
Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci U S A (2007) 4.85
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Crystal structure of a lipid G protein-coupled receptor. Science (2012) 3.78
Serial femtosecond crystallography of G protein-coupled receptors. Science (2013) 3.58
Structure of the human histamine H1 receptor complex with doxepin. Nature (2011) 3.48
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science (2013) 3.17
Structure of the human smoothened receptor bound to an antitumour agent. Nature (2013) 3.08
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science (2012) 3.07
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature (2012) 2.96
Microscale fluorescent thermal stability assay for membrane proteins. Structure (2008) 2.95
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
Structure of the human glucagon class B G-protein-coupled receptor. Nature (2013) 2.86
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol (2009) 2.82
Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam. J R Soc Interface (2009) 2.69
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol (2006) 2.66
Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc (2010) 2.62
Structural features for functional selectivity at serotonin receptors. Science (2013) 2.60
Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3. Structure (2005) 2.55
Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science (2002) 2.50
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature (2008) 2.36
Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A (2006) 2.28
Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. Nat Rev Drug Discov (2009) 2.23
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. Structure (2011) 2.11
Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (2012) 2.08
Discovery of new GPCR biology: one receptor structure at a time. Structure (2009) 2.08
Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J Mol Recognit (2009) 2.05
Automated sample mounting and alignment system for biological crystallography at a synchrotron source. Structure (2004) 2.00
Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care (2014) 1.98
Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature (2006) 1.97
Shotgun crystallization strategy for structural genomics: an optimized two-tiered crystallization screen against the Thermotoga maritima proteome. Acta Crystallogr D Biol Crystallogr (2003) 1.92
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem (2010) 1.88
Nonlinear optical imaging of integral membrane protein crystals in lipidic mesophases. Anal Chem (2010) 1.87
Structural basis for molecular recognition at serotonin receptors. Science (2013) 1.86
Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR. Cell (2013) 1.83